Substituted quinazolines as serine/threonine kinase inhibitors
US9187462B2 · kind B2 · utility
6Cited by
1References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 3, 2012 |
| Grant date | Nov 17, 2015 |
| Priority date | — |
| Expiry date | Aug 3, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having the formula (I) wherein R1, R2, R3 and Ar as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.